Trial Profile
Switching to sirolimus vs continuing calcineurin inhibitors for the prevention of rejection in renal transplant recipients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Calcineurin inhibitors
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 11 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 05 Nov 2010 New trial record.